Skip to main content
. 2020 Aug 29;26(3):365–368. doi: 10.4103/IJPC.IJPC_218_19

Table 1.

Patient characteristics and laboratory values by group comparisons

Survivor (n=36) Nonsurvivor (n=41) P
Age, year 62.8±9.9 63.5±10.0 0.71
Female/male sex (n) 4/32 7/34 0.52
Diagnosis
 Squamous cell carcinoma (n) 20 22 0.94
 Adenocarcinoma (n) 12 15
 Others (n) 4 4
Charlson comorbidity index 8 (6-12) 8 (6-11) 0.90
Time of death after admission, day NA 6 (1-30)
CRP, mg/dl 6.2 (0.1-39.7) 16.1 (1.9-51.5) <0.001
Albumin, g/dl 3.3 (1.9-4.3) 2.8 (1.8-4.1) <0.001
CRP/albumin ratio 2.4 (0.02-1.4) 7 (0.36-22.7) <0.001
Neutrophil/lymphocyte ratio 6.7 (0.3-38.4) 10.3 (0.3-65.4) 0.10
PLR 229 (15.00-697.4) 234.4 (2.50-5215.80) 0.36

CRP: C-reactive protein, NA: Not available, PLR: Platelet/lymphocyte ratio